# The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in Androgenetic Alopecia.

> **NCT06764329** · PHASE1,PHASE2 · ENROLLING_BY_INVITATION · sponsor: **National Institute of Blood and Marrow Transplant (NIBMT), Pakistan** · enrollment: 70 (estimated)

## Conditions studied

- Androgenetic Alopecia
- Androgenetic Alopecia (AGA)

## Interventions

- **BIOLOGICAL:** Mesenchymal Stem Cells
- **OTHER:** 0.9 % saline

## Key facts

- **NCT ID:** NCT06764329
- **Lead sponsor:** National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-12-25
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-08-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06764329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06764329, "The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in Androgenetic Alopecia.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06764329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*